Pro-survival and pro-growth effects of stress-induced nitric oxide in a prostate cancer photodynamic therapy model

Cancer Letters

Volumn 343, Issue 1, 2014, Pages 115-122

  Bhowmick, Reshma ^a   Girotti, Albert W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Nitric oxide; Nitric oxide synthase; Pancreatic cancer; Photodynamic therapy

Indexed keywords

CASPASE 3; CASPASE 7; GUANYLATE CYCLASE; NITRIC OXIDE SYNTHASE;

APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IC 50; IRRADIATION; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; UPREGULATION;

EID: 84890859657     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.09.025     Document Type: Article

References (45)

1. Martinez-Ruiz A., Cadenas S., Lamas S. Nitric oxide signaling: classical, less classical, and non-classical mechanisms. Free Radical. Bio. Med. 2011, 51:17-29.
2. Moncada S.R., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43:109-143.
3. Wink D.A., Mitchell J.B. Chemical biology of nitric oxide: insights into the regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radical. Bio. Med. 1998, 24:434-456.
4. Jenkins C.D., Charles I.G., Thomsen L.L., Moss D.W., Holmes L.S., Baylis S.A., Rhodes P., Westmore K., Emson P.C., Moncada S. Roles of nitric oxide in tumor growth. Proc. Nat. Acad. Sci. USA 1995, 92:4329-4396.
5. Fukumura D., Jain R.K. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev. 1998, 17:77-89.
6. Siegert A., Rosenberg C., Schmitt W.D., Denkert C., Hauptmann S. Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumor cell invasion. Brit. J. Cancer 2002, 87:1310-1315.
7. Niziolek M., Korytowski W., Girotti A.W. Chain-breaking antioxidant and cytoprotective action of nitric oxide on photodynamically stressed tumor cells. Photochem. Photobiol. 2003, 78:262-270.
8. Bhowmick R., Girotti A.W. Signaling events in apoptotic photokilling of 5-aminolevulinic acid-treated tumor cells: inhibitory effects of nitric oxide. Free Radical. Bio. Med. 2009, 47:731-740.
9. Bhowmick R., Girotti A.W. Cytoprotective induction of nitric oxide synthase in a cellular model of 5-aminolevulinic acid-based photodynamic therapy. Free Radical. Bio. Med. 2010, 48:1296-1301.
10. Bhowmick R., Girotti A.W. Rapid upregulation of cytoprotective nitric oxide in breast tumor cells subjected to a photodynamic therapy-like oxidative challenge. Photochem. Photobiol. 2011, 87:378-386.
11. Weller R., Schwentker A., Billiar T.R., Vodovotz Y. Autologous nitric oxide protects mouse and human keratinocytes from ultraviolet B radiation-induced apoptosis. Am. J. Physiol. Cell Physiol. 2003, 284C:1140-1148.
12. Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., Gollnick S.O., Hahn S.M., Hamblin M.R., Juzeniene A., Kessel D., Korbelik M., Moan J., Mroz P., Nowis D., Piette J., Wilson B.C., Golab J. Photodynamic therapy of cancer: an update. CA Cancer J. Clin. 2011, 61:250-281.
13. Peng Q., Berg K., Moan J., Kongshaug M., Nesland J.M. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem. Photobiol. 1997, 65:235-251.
14. Singh D., Richards D., Knowles R.G., Schwartz S., Woodcock A., Langley S., O'Connor B.J. Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma. Am. J. Respir. Crit. Care Med. 2007, 176:988-993.
15. Kriska T., Korytowski W., Girotti A.W. Hyperresistance to photosensitized lipid peroxidation and apoptotic killing in 5-aminolevulinate-treated tumor cells overexpressing mitochondrial GPx4. Free Radical. Bio. Med. 2002, 33:1389-1402.
16. Gray J.W., Coffino P. Cell cycle analysis by flow cytometry. Methods Enzymol. 1979, 58:233-248.
17. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 2001, 357:593-615.
18. Nagano T. Bioimaging probes for reactive oxygen species and reactive nitrogen species. J. Clin. Biochem. Nutr. 2009, 45:111-124.
19. Ryter S.E., Kim H.P., Hoetzel A., Park J.W., Nakahira K., Wang X., Choi A.M.K. Mechanisms of cell death in oxidative stress. Antiox Redox Signal. 2007, 9:49-89.
20. Akaike T., Maeda H. Quantitation of nitric oxide using 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO). Methods Enzymol. 1996, 268:211-222.
21. Haramis G., Zhou Z., Pyriochou A., Koutsilieris M., Roussos C., Papapetropoulos A. CGMP-independent anti-tumor actions of the inhibitor of soluble guanylyl cyclase, ODQ, in prostate cancer cell lines. Br. J. Pharmacol. 2008, 155:804-813.
22. Leung E.L., Wong J.C., Johlfs M.G., Tsang B.K., Fiscus R.R. Protein kinase G type-1α activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell profiferation. Mol. Cancer Res. 2010, 8:578-591.
23. Gomes E.R., Almeida R.D., Carvalho A.P., Duarte C.B. Nitric oxide modulates tumor cell death induced by photodynamic therapy through a cGMP-dependent mechanism. Photochem. Photobiol. 2002, 76:423-430.
24. Bhowmick R., Girotti A.W. Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress. Free Radical. Bio. Med. 2013, 57:39-49.
25. Wada T., Penninger J.M. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004, 23:2838-2849.
26. Siegert A., Rosenberg C., Schmitt W.D., Denkert C., Hauptmann S. Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumor cell invasion. Br. J. Cancer 2002, 86:1310-1315.
27. Pervin S., Singh R., Hernandez E., Wu G., Chaudhuri G. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/elF4E pathway. Cancer Res. 2007, 67:289-299.
28. Kostourou V., Cartwright J.E., Johnstone A.P., Boult J.K.R., Cullis E.R., Whitley G.S.J., Robinson S.P. The role of tumor-derived iNOS in tumor progression and angiogenesis. Br. J. Cancer 2011, 104:83-90.
29. Eyler C.E., Wu Q., Yan K., MacSwords J.M., Chandler-Militello D., Misuraca K.L., Lathia J.D., Forrester M.T., Lee J., Stamler J.S., Goldman S.A., Bredel M., McLendon R.E., Sloan A.E., Hjelmeland A.B., Rich J.N. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 2011, 146:53-66.
30. Sikora A.G., Gelbard A., Davies M.A., Sano D., Ekmekcioglu S., Dwon J., Hailemichael Y., Jayaraman P., Myers J.N., Grimm E.A., Overwijk W.W. Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma cells in vivo and synergizes with chemotherapy. Clin. Cancer Res. 2010, 16:1834-1844.
31. Saleem W., Suzuki Y., Mobaraki A., Yoshida Y., Noda S., Saitoh J., Nakano T. Reduction of nitric oxide level enhances the radiosensitivity of hypoxic non-small cell lung cancer. Cancer Sci. 2011, 102:2150-2156.
32. Gilissen M.J., van de Merbel-de Wit L.E.A., Star W.M., Koster J.F., Sluiter W. Effect of photodynamic therapy on endothelium-dependent relaxation of isolated rat aortas. Cancer Res. 1993, 53:2548-2552.
33. Gupta S., Ahmad N., Mukhtar H. Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis. Cancer Res. 1998, 58:1785-1788.
34. Henderson B.W., Sitnik-Busch T.M., Vaughan L.A. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent. Photochem. Photobiol. 1999, 70:64-71.
35. Korbelik M., Parkins C.S., Shibuya H., Cecic I., Stratford M.R.L., Chaplin D.J. Nitric oxide production by tumor tissue: impact on the response to photodynamic therapy. Br. J. Cancer 2000, 82:1835-1843.
36. Reeves K.J., Reed M.W.R., Brown N.J. The role of nitric oxide in the treatment of tumours with aminolevulinic acid-induced photodynamic therapy. J. Phsotochem. Photobiol. B: Biol. 2010, 101:224-232.
37. Boyd C.S., Cadenas E. Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis. Biol. Chem. 2002, 383:411-423.
38. Park H.S., Huh S.-H., Kim M.-S., Lee S.-H., Choi E.-J. Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein by means of S-nitrosylation. Proc. Natl. Acad. Sci. USA 2000, 97:14382-14387.
39. Park H.S., Wu J.-W., Cho J.H., Kim M.-S., Huh S.-H., Ryoo K., Choi E.-J. Inhibition of apoptosis signal-regulating kinase 1 by nitric oxide through a thiol redox mechanism. J. Biol. Chem. 2004, 279:7484-7490.
40. Guan W., Sha J., Chen X., Xing Y., Yan J., Wang Z. S-nitrosylation of mitogen activated protein kinase phosphatase-1 suppresses radiation-induced apoptosis. Cancer Lett. 2012, 314:137-146.
41. Zhang X., Jiang F., Zhang Z.G., Kalkanis S.N., Hong X., deCarvalho A.C., Chen J., Yang H., Robin A.M., Chopp M. Low-dose photodynamic therapy increases endothelial cell proliferation and VEGF expression in nude mice brain. Laser Med. Sci. 2005, 20:74-79.
42. Chen J.-H., Tseng T.-H., Ho Y.-C., Lin H.-H., Lin W.-L., Wang C.J. Gaseous nitrogen oxides stimulate cell cycle progression by retinoblastoma phosphorylation via activation of cyclins/cdks. Toxicol. Sci. 2003, 76:83-90.
43. Kumar S., Barthwal M.K., Dikshit M. Nitrite-mediated modulation of HL-60 cell cycle and proliferation: involvement of cyclin-dependent kinase 2 activation. J. Pharm. Exp. Therm. 2011, 337:812-821.
44. Ferrario A., von Tiehl K., Wong S., Luna M., Gomer C.J. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. Cancer Res. 2002, 62:3956-3961.
45. Crowell J.A., Steele V.E., Sigman C.C., Fay J.R. Is inducible nitric oxide synthase a target for chemoprevention?. Mol. Cancer Therm. 2003, 2:815-823.